Clinical trial

Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia

NCT00327054

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Nigella sativa seed Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-02-01

PhasePHASE1 / PHASE2

Conditions

Hypercholesterolemiaunresolved

Hypertensionunresolved

Diabetes Mellitusverified · MONDO: diabetes mellitus

Metabolic Syndrome Xverified · MONDO: metabolic syndrome X

Interventions

Nigella sativa seedDRUG

Sponsors & collaborators

Aga Khan Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00327054 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.